Stay up to date with the latest in HIV treatment and prevention, including LEN and CAB/RPV, and explore key updates to the ARV guidelines. This session will cover ASHM resources, the LAI HIV Treatment Tool, and best practices for transitioning patients from oral regimens to injectables, with a focus on patient-centered care.
Date, Time & Platform:
Date: Tuesday,15 July 2025
Time: 7:00 – 8:00pm (AWST)
Platform: Microsoft Teams Webinar
Target Audience:
HIV s100 Prescribers in Western Australia
Speakers/Facilitators:
Lewis Mackinnon, Director and Principal Doctor, Skye Medical
Learning Outcomes:
- Apply updated ARV guidelines and interactive tools (e.g., Long Acting Injectables HIV Treatment Decision Making tool) to support clinical decision-making.
- Explain the role of lenacapavir and cabenuva/rilpivirine in HIV treatment and prevention, including their benefits and limitations.
- Evaluate patient-centered approaches for transitioning from oral regimens to injectables, considering individual needs and preferences.
Endorsement and CPD:
HIV s100 Prescribers will receive 2 ASHM HIV Prescriber Points for attending the session.
This session is pending accreditation with RACGP and ACRRM
Funding:
This activity is funded by the Western Australian Department of Health.
For more information:
Please contact ASHM Education at [email protected] or call 0431 320 429.
Help us keep ASHM courses free!
At ASHM, we are committed to developing a sustainable HIV, viral hepatitis, and sexual health workforce. We pride ourselves on the ability to offer high quality educational opportunities, that are free to attend. If you are unable to attend one of our courses, please let us know as soon as possible, high rates of non-attendance impacts ASHMs ability to continue providing free education. You can cancel your attendance by calling 0431 320 429 or emailing [email protected].
